Can e-Health improve post-marketing surveillance of drugs and vaccines? The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised controlled trial. [ 2013 - 2017 ]

Also known as: The STARSS e-Health system for post-marketing safety surveillance of drugs and vaccines.

Research Grant

[Cite as]

Researchers: Prof Michael Gold (Principal investigator) ,  Prof Annette Braunack-Mayer Prof Jim Buttery Dr Paul Effler Prof Kristine Macartney
View all 6 related researchers

Brief description Despite the considerable benefits of vaccination there is public concern about the safety of newly introduced or seasonal influenza vaccines. Loss of confidence in vaccine safety can result in decreased vaccine coverage and resurgence of disease. The current system of monitoring vaccines after licensure is unable to detect all important adverse events following immunisation. The proposed study evaluates web based communication and mobile phone text messaging to identify adverse events following immunisation.

Funding Amount $AUD 445,368.26

Funding Scheme Partnerships

Notes Partnership Project for Better Health

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]